The Authors Respond.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32857661.
- Also identified by DOI 10.18553/jmcp.2020.26.9.1177a and PMC identifier 10391034.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
No funding was received for the writing of this letter. Simpson reports consulting honoraria for participation in advisory boards for Bayer, CSL Behring, HEMA Biologics, Novo Nordisk, Octapharma and Takeda, and speakers bureau for Bayer and Novo Nordisk; Yan and Desai are employees of CSL Behring; Maro is an employee of Adivo Associates.